IPP Bureau
Casper Pharma receives EIR from USFDA for its PAI
By IPP Bureau - October 05, 2022
The inspection concluded with no observation (FDA-483) issued.
Medcare acquires 60% stake in Skin III
By IPP Bureau - October 05, 2022
This acquisition will accelerate Medcare's plans to emerge as an international hub for health, beauty, and wellness adding to its existing network of 4 hospitals and over 20 medical centres in the UAE.
Zydus receives USFDA tentative approval for Amantadine Extended-Release capsules
By IPP Bureau - October 05, 2022
Amantadine Extended-Release capsules had annual sales of US $2.7 million in the United States according to IQVIA data
Wockhardt Hospitals, Mira Road starts a Comprehensive Clinic for Cancer Patients
By IPP Bureau - October 05, 2022
Specialized cancer care will be offered to cancer patients making it accessible and affordable. We have adopted a patient-centric approach.
Zydus receives approval from USFDA for Mirabegron Extended-Release Tablets
By IPP Bureau - October 04, 2022
Mirabegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urinary incontinence, urgency, and frequency
AGC begins study to expand its Bio-CDMO capability in Japan
By IPP Bureau - October 04, 2022
Shionogi and MPP sign licence agreement for COVID-19 oral antiviral treatment
By IPP Bureau - October 04, 2022
Ensitrelvir is being evaluated for the treatment of COVID-19 to be administered as an oral tablet formulation taken once daily for five days.
Fluor bags award for Biologics manufacturing facility in Scandinavia
By IPP Bureau - October 04, 2022
Construction is now underway with the facility scheduled to be operational by 2025
Matt Sause elevated as new CEO of Roche Diagnostics
By IPP Bureau - October 04, 2022
Sause will become CEO Roche Diagnostics and a member of the Corporate Executive Committee effective 1 January 2023.
Moderna creates new executive committee role for product launches
By IPP Bureau - October 04, 2022
Juan Andres Appointed to President, Strategic Partnerships and Enterprise Expansion
2.5 lakh+ people voluntarily donated blood under the Raktdaan Amrit Mahotsav
By IPP Bureau - October 03, 2022
Mandaviya felicitated voluntary blood donors and states/UTs that have done exemplary work
Lupin gets EIR from USFDA for its Ankleshwar facility
By IPP Bureau - October 03, 2022
The inspection of the facility was conducted from August 16-19, 2022.
SPARSH Hospitals, MGM Healthcare, Chennai to offer heart failure management program in Bengaluru
By IPP Bureau - October 03, 2022
This new initiative will cater to the increasing number of patients in Karnataka in need of heart and lung Failure management and transplant
Sumitovant Biopharma and Sumitomo Pharma to acquire outstanding shares of Myovant Sciences
By IPP Bureau - October 03, 2022
The proposed acquisition consideration represents an equity value for Myovant of $2.4 billion and an enterprise value of $2.5 billion.
Lupin Life announces association with Vikram Vedha as official energy partner
By IPP Bureau - October 02, 2022
Enriched with eight ayurvedic active ingredients like Ashwagandha, Shilajit, Shatavari, and Pippali, Be One works holistically to provide energy, build immunity and enable a healthy body and mind
